MEYER DONALD A 4
4 · EZ EM INC · Filed Apr 21, 2005
Insider Transaction Report
Form 4
EZ EM INCEZM
MEYER DONALD A
Director
Transactions
- Sale
Common Stock
2005-04-19$12.80/sh−5,200$66,560→ 6,444 total - Sale
Common Stock
2005-04-19$12.85/sh−6,444$82,805→ 0 total - Exercise/Conversion
Common Stock Option
2005-04-19−995→ 0 totalExercise: $2.52From: 1996-06-03Exp: 2005-06-02→ Common Stock (995 underlying) - Exercise/Conversion
Common Stock
2005-04-19$8.08/sh+967$7,813→ 1,962 total - Exercise/Conversion
Common Stock Option
2005-04-19−967→ 0 totalExercise: $8.08From: 1997-06-01Exp: 2006-05-31→ Common Stock (967 underlying) - Exercise/Conversion
Common Stock Option
2005-04-19−9,682→ 0 totalExercise: $6.63From: 1998-03-04Exp: 2007-03-03→ Common Stock (9,682 underlying) - Exercise/Conversion
Common Stock
2005-04-19$2.52/sh+995$2,507→ 995 total - Exercise/Conversion
Common Stock
2005-04-19$6.63/sh+9,682$64,192→ 11,644 total
Holdings
- 912
Common Stock Option
Exercise: $3.80From: 1999-05-30Exp: 2008-05-29→ Common Stock (912 underlying) - 940
Common Stock Option
Exercise: $4.79From: 1998-05-31Exp: 2007-05-30→ Common Stock (940 underlying) - 32,413(indirect: By Trust)
Common Stock
Footnotes (8)
- [F1]Options granted under E-Z-EM's Directors and Consultants Stock Option Plan.
- [F2]This option was previously reported as covering 1,030 shares at an exercise price of $7.4029 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $4.7890 per share and the number of shares was reduced to 940, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off.
- [F3]This option was previously reported as covering 1,000 shares at an exercise price of $5.875 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $3.8006 per share and the number of shares was reduced to 912, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off.
- [F4]This option was previously reported as covering 1,000 shares at an exercise price of $5.00 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $3.2346 per share and the number of shares was reduced to 912, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off.
- [F5]This option was previously reported as covering 1,000 shares at an exercise price of $6.50 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $4.2049 per share and the number of shares was reduced to 912, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off.
- [F6]This option was previously reported as covering 1,000 shares at an exercise price of $5.20 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $3.3639 per share and the number of shares was reduced to 912, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off.
- [F7]This option was previously reported as covering 1,000 shares at an exercise price of $9.00 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $5.8222 per share and the number of shares was reduced to 912, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off.
- [F8]This option was previously reported as covering 1,000 shares at an exercise price of $8.40 per share. As a result of the spin-off by E-Z-EM, Inc. of AngioDynamics, Inc. on October 30, 2004, the exercise price was reduced to $5.4340 per share and the number of shares was reduced to 912, to maintain, together with AngioDynamics options granted to the reporting person, the economic value of the option before the spin-off.